NFKB1 and psoriasis: On the contrary, TG3 is upregulated in psoriasis and acts as a protective factor by inhibiting the activation of nuclear factor kappa-B (NF-κB) through the phosphorylated STAT3-ten-eleven translocase 3 (p-STAT3-TET3) pathway, which thereby reduces skin inflammation (51, 52).